Ikuo Hirano (I Hirano)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 17

Top Topics

Endoscopic Submucosal Dissection

Chronic Rhinosinusitis

Top Venues

Alimentary pharmacology & therapeutics

The American journal of gastroenterology

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ikuo Hirano, Marc E Rothenberg, Sandra Zhang, Claudia de Oliveira, Christina M Charriez, Karin S Coyne, Elizabeth Dansie Bacci, Evan S Dellon
Dysphagia Days as an Assessment of Clinical Treatment Outcome in Eosinophilic Esophagitis. The American journal of gastroenterology (2023)
Ikuo Hirano, Evan S Dellon, Sandeep K Gupta, David A Katzka, Margaret H Collins, Abigail M Wojtowicz, Brian Terreri, Wenwen Zhang, Mena Boules, Siddharth Bhatia, Nirav K Desai
Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis - new data bring new questions. Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Evan S Dellon, Kathryn A Peterson, Benjamin L Mitlyng, Alina Iuga, Christine E Bookhout, Lindsay M Cortright, Kacie B Walker, Timothy S Gee, Sarah J McGee, Brenderia A Cameron, Joseph A Galanko, John T Woosley, Swathi Eluri, Susan E Moist, Ikuo Hirano
Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Gut (2023)
Ikuo Hirano, Evan S Dellon, Sandeep K Gupta, David A Katzka, Margaret H Collins, Abigail M Wojtowicz, Brian Terreri, Wenwen Zhang, Mena Boules, Siddharth Bhatia, Nirav K Desai
Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis - new data bring new questions. Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Ikuo Hirano, Evan S Dellon, Sandeep K Gupta, David A Katzka, Margaret H Collins, Abigail M Wojtowicz, Brian Terreri, Wenwen Zhang, Mena Boules, Siddharth Bhatia, Nirav K Desai
Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis - new data bring new questions. Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Ikuo Hirano, David Katzka
Comparing the relative efficacy of therapeutics for eosinophilic oesophagitis: is counting eosinophils the right target? Gut (2023)
Ikuo Hirano, Evan S Dellon, Sandeep K Gupta, David A Katzka, Margaret H Collins, Abigail M Wojtowicz, Brian Terreri, Wenwen Zhang, Mena Boules, Siddharth Bhatia, Nirav K Desai
Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1-3 clinical trials. Alimentary pharmacology & therapeutics (2023)
Ikuo Hirano, Evan S Dellon, Sandeep K Gupta, David A Katzka, Margaret H Collins, Abigail M Wojtowicz, Brian Terreri, Wenwen Zhang, Mena Boules, Siddharth Bhatia, Nirav K Desai
Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis - new data bring new questions. Authors' reply. Alimentary pharmacology & therapeutics 57 (10) (2023)
Albert J Bredenoord, Evan Dellon, Ikuo Hirano, Alfredo J Lucendo, Christoph Schlag, Xian Sun, Lila Glotfelty, Leda Mannent, Jennifer Maloney, Elizabeth Laws, Eric Mortensen, Arsalan Shabbir
Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study. Gut (2023)
Ikuo Hirano, Margaret H Collins, Eileen King, Qin Sun, Mirna Chehade, J Pablo Abonia, Peter A Bonis, Kelly E Capocelli, Evan S Dellon, Gary W Falk, Nirmala Gonsalves, Sandeep K Gupta, John Leung, David Katzka, Paul Menard-Katcher, Paneez Khoury, Amy Klion, Vincent A Mukkada, Kathryn Peterson, Tetsuo Shoda, Amanda K Rudman-Spergel, Jonathan A Spergel, Guang-Yu Yang, Marc E Rothenberg, Seema S Aceves, Glenn T Furuta, null null
Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort. The American journal of gastroenterology 117 (3) (2022)
Ikuo Hirano, Marc E Rothenberg, Sandra Zhang, Claudia de Oliveira, Christina M Charriez, Karin S Coyne, Elizabeth Dansie Bacci, Evan S Dellon
Dysphagia Days as an Assessment of Clinical Treatment Outcome in Eosinophilic Esophagitis. The American journal of gastroenterology (2022)
Luay M Almassalha, Ikuo Hirano
Editorial: cooking up something new for diet therapy of eosinophilic oesophagitis. Alimentary pharmacology & therapeutics 56 (7) (2022)
Brent Hiramoto, Angelika Zalewski, Dyanna Gregory, Guang-Yu Yang, Nancy Ho, Nirmala Gonsalves, Ikuo Hirano
Low Prevalence of Extraesophageal Gastrointestinal Pathology in Patients with Eosinophilic Esophagitis. Digestive diseases and sciences (2021)
Ikuo Hirano, Ekaterina Safroneeva, Marie C Roumet, Gail M Comer, Gina Eagle, Alain M Schoepfer, Gary W Falk
Editorial: fluticasone propionate orally disintegrating tablets-interesting concept but is it going anywhere? Authors' reply. Alimentary pharmacology & therapeutics 51 (10) (2020)
Ikuo Hirano, Ekaterina Safroneeva, Marie C Roumet, Gail M Comer, Gina Eagle, Alain M Schoepfer, Gary W Falk
Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis. Alimentary pharmacology & therapeutics 51 (8) (2020)
Ikuo Hirano
Clinical relevance of esophageal subepithelial activity in eosinophilic esophagitis. Journal of gastroenterology 55 (3) (2019)
N Gonsalves, Ikuo Hirano
Editorial: long-term effectiveness of elimination diet therapy for eosinophilic oesophagitis-is the glass half full or half empty? Alimentary pharmacology & therapeutics 47 (1) (2017)